A woman from Brentwood has become the first patient at Vanderbilt Health to receive a new FDA-approved heart valve device. The M3 device is a transseptal transcatheter mitral valve replacement, which allows for a quick and painless procedure. This development provides new options for high-risk patients who may not have had other choices.

The procedure has the potential to improve the quality of life for these patients, allowing them to live a healthier and longer life.

Further details about the M3 device and its implications for heart patients are available from the source.